1,132 results on '"Vogel, Martin"'
Search Results
102. Test results of the 18 kA EDIPO HTS current leads
103. HIV/HCV-coinfection: which role can new antiretrovirals such as integrase inhibitors play?
104. Comparative effectiveness of ciltacabtagene autoleucel in CARTITUDE‐1 versus physician's choice of therapy in the Flatiron Health multiple myeloma cohort registry for the treatment of patients with relapsed or refractory multiple myeloma
105. Design of PCB-based planar coil inductive coupler
106. Comparative Efficacy of Ciltacabtagene Autoleucel in CARTITUDE-1 vs Physician’s Choice of Therapy in the Long-Term Follow-Up of POLLUX, CASTOR, and EQUULEUS Clinical Trials for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
107. Placenta Percreta Presents with Neoangiogenesis of Arteries with Von Willebrand Factor-Negative Endothelium
108. CARTITUDE-2: Efficacy and Safety of Ciltacabtagene Autoleucel, a B-Cell Maturation Antigen (BCMA)-Directed Chimeric Antigen Receptor T-Cell Therapy, in Patients with Multiple Myeloma and Early Relapse after Initial Therapy
109. Efficacy and Safety of Ciltacabtagene Autoleucel (Cilta-cel), a B-Cell Maturation Antigen (BCMA)-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy, in Lenalidomide-Refractory Patients with Progressive Multiple Myeloma after 1-3 Prior Lines of Therapy: Updated Results from CARTITUDE-2
110. LocoMMotion: A Prospective, Non-Interventional, Multinational Study of Real-Life Current Standards of Care in Patients With Relapsed/Refractory Multiple Myeloma Who Received ≥3 Prior Lines of Therapy
111. Anakinra Targeting Cytokine Release Syndrome Associated with Chimeric Antigen Receptor T-Cell Therapies
112. Meta-Analysis of Ciltacabtagene Autoleucel Versus Physician's Choice in the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
113. Aircraft DC networks characterization and adaptive stage design for PLC use
114. OAB-023: Efficacy and safety of ciltacabtagene autoleucel, a BCMA-directed CAR-T cell therapy, in patients with progressive multiple myeloma after 1–3 prior lines of therapy: Initial results from CARTITUDE-2
115. Bauherren im Clinch mit ökologischen Forderungen
116. Enabling the detection of UV signal in multimodal nonlinear microscopy with catalogue lens components
117. Extracorporeal Shock Wave Therapy For Plantar Fasciitis: Randomised Controlled Multicentre Trial
118. Anregendes Griechentum
119. sumer von triere bei Friedrich von Hausen
120. Epiplacental arteries in placenta percreta present Von Willebrand factor-negative endothelium
121. Full or intensity‐reduced high‐dose melphalan and single or double autologous stem cell transplant with or without bortezomib consolidation in patients with newly diagnosed multiple myeloma
122. Matching-adjusted indirect comparison of efficacy outcomes for ciltacabtagene autoleucel in CARTITUDE-1 versus idecabtagene vicleucel in KarMMa for the treatment of patients with relapsed or refractory multiple myeloma
123. Unterwachung revisited
124. Katja Dettmer-Wilde and Werner Engewald (Eds): Practical gas chromatography: a comprehensive reference
125. Evidence of a Large, International Network of HCV Transmission in HIV-Positive Men Who Have Sex With Men
126. Ein anderes Buch über Aktionsforschung in Organisationen: Rezension zu 'Action Research in Organizations - Participation in Change Processes' von Marianne Kristiansen und Jørgen Bloch-Poulsen
127. LOCAL EIGENVALUE STATISTICS OF ONE DIMENSIONAL RANDOM NONSELFADJOINT PSEUDODIFFERENTIAL OPERATORS
128. Gemeinsame Erklärung des Max-Planck-Nachhaltigkeitsnetzwerk und des Netzwerk Helmholtz Klimaneutral zur Stellungnahme der Allianz der Wissenschaftsorganisationen zum Ziel der Klimaneutralität
129. Deterministic equivalence for noisy perturbations
130. CARTITUDE-2: Efficacy and safety of ciltacabtagene autoleucel (cilta-cel), a BCMA-directed CAR T-cell therapy, in patients with progressive multiple myeloma (MM) after one to three prior lines of therapy.
131. Comparison of outcomes with ciltacabtagene autoleucel (cilta-cel) in CARTITUDE-1 versus real-world standard of care (RW SOC) for patients (pts) with triple-class exposed relapsed/refractory multiple myeloma (RRMM).
132. Relaxation Behavior of Aircraft Tires
133. Investigation of the interaction of Mercurochrome® constituents with proteins using liquid chromatography/mass spectrometry
134. Motor protein function in skeletal muscle--a multiple scale approach to contractility
135. CARTITUDE-2: Phase 2 Multicohort Study of Ciltacabtagene Autoleucel, a B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T-Cell Therapy, in Patients with Multiple Myeloma
136. New Features in Feko and WinProp 2019
137. Hajo Rupp: Die Rechtfertigung der Leistungsschutzrechte des Tonträgerherstellers. Begründungsansätze für den Schutz von Tonaufnahmen in der Musikwirtschaft. Baden-Baden: Nomos, 2021 (Schriftenreihe de
138. Determination of airborne isocyanates
139. Recent methods for the determination of peroxide-based explosives
140. Management des Ungefähren: Zur außer-ordentlichen Position von Stellvertretern in Organisationen
141. Passung ins System – Möglichkeiten einer systemischen Personalauswahl
142. Zukunft in Organisationen – Ordnung aus der Außer-Ordentlichkeit
143. Wie ist (ordentliche) Organisation möglich? Von Personen und Erwartungen
144. Zur Einführung – so viel Ordnung muss sein …
145. Humor in Organisationen – Kommunikation , quer zur Ordnung
146. »Nur gucken – nicht anfassen!« Zum Management von Organisationskulturen
147. Pathologie der Plazenta: Spätschwangerschaft und fetoplazentare Einheit
148. Pathologie der Fetalperiode
149. Pathologie der Plazenta: Frühschwangerschaft und Abort
150. Passive sampling of airborne peroxyacetic acid
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.